Cell and Gene Therapy (CAGT)
Providing industry-leading science and innovative laboratory solutions across the cell and gene therapy spectrum.
The use of alternative treatments such as Cell and Gene Therapies (CAGT) holds great potential for bridging the gaps left by traditional treatments. These innovative CAGT clinical development programs require a suite of complex laboratory assessments to satisfy regulatory submissions and support Proof of Mechanism, Pharmacodynamic, Safety and Efficacy investigations. Q2 Solutions, with its global laboratory network and industry leading subject matter experts, is ideally positioned to shape, validate, and deliver those biomarker assessments.
Download our factsheet to learn more